Self-Injection Device Market Report Examines Latest Trends and Key Drivers Supporting Growth Through 2026
At the time when new biologic and bio-similar products are launching, the significance of self-injection devices for biopharmaceuticals have strengthened. Self-injection devices, including pen injectors, auto injectors and new large volume patch injectors have been designed for convenience and improved patient adherence. Cost pressure and timeline are fueling both pharmaceutical and biotech companies to source these state-of-the-art device swiftly and at low risk.
View full press release